help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erben, R. G.
Right arrow Articles by Hofbauer, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erben, R. G.
Right arrow Articles by Hofbauer, L. C.
Endocrinology Vol. 144, No. 1 40-49
Copyright © 2003 by The Endocrine Society


ARTICLE

Skeletal Effects of Cyclosporin A Are Gender Related in Rats

Reinhold G. Erben, Katrin S. Brunner, Bianca Breig, Johannes Eberle, Michel Goldberg and Lorenz C. Hofbauer

Institute of Physiology (R.G.E., K.S.B., B.B., J.E., M.G.), Physiological Chemistry and Animal Nutrition, Ludwig Maximilians University, 80539 Munich, Germany; and Division of Gastroenterology and Endocrinology (L.C.H.), Philipps University, 35033 Marburg, Germany

Address all correspondence and requests for reprints to: Reinhold G. Erben, M.D., D.V.M., Institute of Animal Physiology, University of Munich, Veterinaerstrasse 13, D-80539 Munich, Germany. E-mail: r.erben{at}lrz.uni-muenchen.de.

The immunosuppressive drug cyclosporin A (CsA) is thought to be involved in the pathogenesis of posttransplantation osteoporosis. To evaluate further the skeletal effects of CsA, we treated aged male and female sham-operated and gonadectomized rats with low doses of CsA for 4 months. Here, we show that CsA is antiresorptive and bone-sparing in aged female rats but increases bone resorption and reduces bone mass in aged male rats. However, even in male rats, CsA treatment, at clinically relevant doses, increased bone resorption only transiently and did not result in pronounced long-term cancellous bone loss. The gender-specific skeletal effects of CsA were not modulated by sex hormones or gonadectomy. CsA did not influence sex steroid metabolism in male or female rats. However, endogenous estradiol in sham-operated female rats (and especially, exogenous administration of 17ß-estradiol in ovariectomized rats) markedly diminished blood levels of CsA, probably by increasing hepatic CsA metabolism. Although the mechanism for the gender-specific skeletal effects of CsA is still obscure, our findings may have important implications for clinical therapy with CsA.




This article has been cited by other articles:


Home page
LupusHome page
O Di Munno, M Mazzantini, A D. Sedie, M Mosca, and S Bombardieri
Risk factors for osteoporosis in female patients with systemic lupus erythematosus
Lupus, September 1, 2004; 13(9): 724 - 730.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society